Anticipatory nausea and vomiting: Does it remain a significant clinical problem?

Nausea and emesis remain significant pro

Nausea and emesis remain significant problems of chemotherapy despite prophylaxis with 5-hydroxytryptamine-3 antiemetics : A University of Rochester James P. Wilmot Cancer Center Community Clinical Oncology Program study of 360 cancer patients treated in the community

✍ Jane T. Hickok; Joseph A. Roscoe; Gary R. Morrow; David K. King; James N. Atkins 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 93 KB

## Abstract ## BACKGROUND Clinical reports suggest that nausea remains a side effect of chemotherapy despite widespread use of serotonin receptor antagonists. This study summarized the frequency, timing, and intensity of postchemotherapy nausea for patients receiving doxorubicin, cisplatin, or car